Y. Shiroshita

The site of the anti-emetic action of tachykinin NK1 receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus

T. Koga, Emi Nakamura, H. Fukuda, 1999, Brain Research.

The tachykinin NK1 receptor antagonist GR205171 abolishes the retching activity of neurons comprising the central pattern generator for vomiting in dogs

T. Koga, Emi Nakamura, H. Fukuda, 1999, Neuroscience Research.

The tachykinin NK1 receptor antagonist GR205171 prevents vagal stimulation-induced retching but not neuronal transmission from emetic vagal afferents to solitary nucleus neurons in dogs

T. Koga, Emi Nakamura, H. Fukuda, 1998, Brain Research.

PHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER DRUGS

T. Endo, M. Minami, Y. Monma, 1991 .

A neurokinin-1 receptor antagonist reduced hypersalivation and gastric contractility related to emesis in dogs.

T. Koga, H. Fukuda, N. Furukawa, 1998, American journal of physiology. Gastrointestinal and liver physiology.

A neurokinin-1 receptor antagonist reduced hypersalivation and gastric contractility related to emesis in dogs.

T. Koga, H. Fukuda, N. Furukawa, 1998, The American journal of physiology.

An automated evaluation system for analyzing antinociceptive effects on intracolonic capsaicin-induced visceral pain-related licking behavior in mice.

Hideaki Hara, H. Hara, Etsuko Hayashi, 2011, Journal of pharmacological and toxicological methods.

The protective effect of 4-hydroxy-2-methyl-N-[2-(tetrazol-5-yl)- phenyl]-2H-1, 2-benzothiazine-3-carboxamide-1, 1-dioxide monosodium salt (HX-1920) on cisplatin-induced toxicity in rats.

T. Satoh, T. Endo, M. Minami, 1993, The Journal of toxicological sciences.